Clinical Trials
13 trialsNCT04655144 2026-01-07
Dex-Fib
University of Miami
Phase 3 Completed
NCT04410042 2024-12-20
Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure
St. Jude Children's Research Hospital
Phase 3 Terminated
NCT02950155 2024-10-26
Rinomax
Karolinska Institutet
Phase 3 Completed
NCT03233828 2024-07-24
IL-2
Nova Scotia Health Authority
Phase 3 Terminated
NCT04571645 2024-04-15
AML
Jazz Pharmaceuticals
Phase 3 Terminated
NCT04095858 2023-02-08
CATHY
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT03027557 2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3 Completed
NCT01806259 2020-04-07
KBCt
Université Catholique de Louvain
Phase 3 Completed
NCT01591746 2019-10-10
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Mayo Clinic
Phase 3 Completed
NCT02049151 2017-08-23
START2
EMD Serono
Phase 3 Terminated
NCT01539317 2017-04-14
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
OHSU Knight Cancer Institute
Phase 3 Completed
NCT01015443 2016-10-26
INSPIRE
Merck KGaA, Darmstadt, Germany
Phase 3 Terminated
NCT00925548 2014-07-24
STRIDE
EMD Serono
Phase 3 Terminated